Latest News of TGTX
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
By Yahoo! Finance |
2 weeks ago
Adam Waldman expects BRIUMVI's market share in the anti-CD 20 market for MS to grow to the mid-50s or even 60% by 2025....
Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025?
By Yahoo! Finance |
3 weeks ago
A list of 10 stocks set to explode in 2025 includes TG Therapeutics, Inc. and big tech companies. Nancy Tengler highlights big tech's strong market position and suggests investing in tech over traditi...
TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish
By Yahoo! Finance |
2 months ago
A list of the worst 52-week high stocks includes TG Therapeutics Inc. Despite positive results, the company faces high short interest due to concerns about drug competition and patent expiration. Fina...
-
TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory
By Yahoo! Finance | 2 months agoTG Therapeutics (TGTX) is a biopharmaceutical company excelling in treatments for B-cell mediated diseases, with a promising flagship product, Briumvi, targeting Multiple Sclerosis. The company's fina...
-
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 3 months agoTG Therapeutics, Inc. is a biopharmaceutical company focusing on innovative treatments for B-cell mediated diseases. Their products include BRIUMVI for multiple sclerosis and Umbralisib for lymphoma. ...
-
Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)
By Yahoo! Finance | 5 months agoTG Therapeutics Inc is a biopharmaceutical company specializing in treatments for B-cell malignancies and autoimmune diseases. Insider selling trends, stock valuation metrics, and GF Value estimates s...